Skip to main content

NIH funding Archives

Grant to advance prevention of hospital-acquired blood clots

Nov. 10, 2023—A Vanderbilt team team will develop and test new clinical decision support tools to facilitate timely prevention of potentially lethal hospital-acquired blood clots, also known as venous thromboembolism.

Read more


Pancreas “crosstalk” may influence course of Type 1 and Type 2 diabetes

Nov. 1, 2023—In the largest study of its kind, researchers at Vanderbilt have identified unexpected alterations in the exocrine tissues of the pancreas that occur in the two major forms of diabetes, and with aging and obesity.

Read more


Grant bolsters research to address rising maternal mortality rates

Oct. 27, 2023—Study seeks to better understand the mechanism behind the association between preeclampsia and other hypertensive disorders of pregnancy and cardiovascular disease.

Read more


VISE-affiliated researchers conduct phase 1 trial of novel magnetic endoscope for colonoscopies

Oct. 17, 2023—A Vanderbilt research team is conducting the first phase 1 clinical trial of a magnetic, flexible endoscope that has the potential to provide a safer alternative to standard colonoscopy, particularly for individuals with inflammatory bowel disease.

Read more


Vulnerability found in immunotherapy-resistant triple-negative breast cancer

Oct. 4, 2023—Vanderbilt researchers have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.

Read more


Research fellowship for genetic counselors established at Vanderbilt

Oct. 3, 2023—Vanderbilt University School of Medicine has received a grant to establish a research fellowship for genetic counselors that will prepare them to contribute more fully to the advancement of personalized medicine.

Read more


$51 million NIH grant brings ELVIS to VUMC

Sep. 19, 2023—Vanderbilt University Medical Center scientists are launching a research platform called ELVIS that is devoted to molecular underpinnings of early-childhood determinants of health.

Read more


Grant aids drug discovery for autism, schizophrenia

Aug. 17, 2023—Federal grant to help Vanderbilt researchers will pave the way for potential treatments for schizophrenia and autism spectrum disorder

Read more


Predicting gene expression may speed discovery: study

Jul. 20, 2023—Researchers at Vanderbilt University Medical Center and the University of Cambridge have developed a method of or predicting gene expression in hard-to-access tissues like the brain from more accessible tissues, including whole blood.

Read more


NIH grant launches C. diff vaccine research initiative

Mar. 30, 2023—Vanderbilt has received an NIH grant to launch the Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines, or VANDy-CdV.

Read more


Study sheds light on drug’s impact on diabetes progression

Mar. 23, 2023—A Vanderbilt study of a treatment to delay the development of Type 1 diabetes in individuals at high risk did not meet the study goals of delaying progression from normal glucose tolerance to abnormal glucose tolerance or clinical diagnosis, although the study drug, abatacept, impacted immune response and preserved insulin production during the one-year treatment period.

Read more


NIH grant supports TB research network in Brazil

Feb. 23, 2023—The National Institutes of Health has awarded a five-year, $5 million grant to Vanderbilt University Medical Center for continued support of the Brazil Regional Prospective Observational Research in Tuberculosis network, or RePORT-Brazil.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more